Search Doctor

ASSOC.PROF. CHUTIMA KUNACHEEWA

Hematology
Make an Appointment
Departments
Hematology
Specialty
Internal Medicine
Languages
English, Thai

2002
Doctor of Medicine, Doctor of Medicine, Faculty of Medicine, Chulalongkorn University, Thailand

  • 2561 - 2562 : ประกาศนียบัตร , อายุรศาสตร์โลหิตวิทยา การปลูกถ่ายเซลล์ต้นกำเนิดเม็ดเลือดในผู้ใหญ่ , Multiple Myeloma , The University of Texas MD Anderson Cancer Center , USA
  • 2552 - 2555 : วุฒิบัตร/อนุมัติบัตร , อายุรศาสตร์โลหิตวิทยา , คณะแพทยศาสตร์ ศิริราชพยาบาล , มหาวิทยาลัยมหิดล , ประเทศไทย

  • Multiple Myeloma

  • Hematopoietic Stem Cell Transplantation (HSCT)
  • Autologous Stem Cell Transplantation (ASCT)
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Chemotherapy Administration
  • Targeted Therapy
  • Diagnosis and Management of Hematologic Malignancies
  • Multiple Myeloma Treatment
  • Bone Marrow Examination

  • -Assistant Professor at the Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University.
  • -2019 Visiting Faculty Certification in Multiple Myeloma from The University of Texas MD Anderson Cancer Center, USA

  • -The Thai Society of Hematology
  • -Medical Council of Thailand
  • -Thai Cancer Society (TCS) / Thai Cancer Society Foundation
  • -Asian Myeloma Network (AMN)
  • -Faculty of Medicine Siriraj Hospital, Mahidol University
  • -Siriraj Piyamaharajkarun Hospital (SiPH)

  • - Efficacy of Lenalidomide plus Low-Dose Dexamethasone in Thai Patients with Relapsed and/or Refractory Multiple Myeloma
  • - High-risk smoldering myeloma versus early detection of multiple myeloma: Current models, goals of therapy, and clinical implications
  • - Optimizing Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Early Step-Down Ward Versus HEPA-Filtered Rooms: A Practical Approach for Resource-Limited Settings

For appointments & inquiries please contact
Doctor Appointment Call : 02-734-0000

Publications

0 Patient Satisfaction Review

There are no reviews yet. Be the first one to write one.